Neogenomics Inc (NEO) Price Targets From Analysts
Use the tables below to see what analysts covering Neogenomics Inc think about its future price and what recommendations they have for investors and traders.
| Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|
| 10 | $66 | $60 | $63.2 | $48.91 | 29.22% |
The Trend in the Analyst Price Target
NEO's average price target has moved up $21.14 over the prior 189 days.
NEO reports an average of 9.18% for its upside potential over the past 315 days.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2020-05-30 | 6 | 36.0 | 32.0 | 34.00 | 26.69 | 27.39% |
| 2020-06-25 | 7 | 36.0 | 32.0 | 34.00 | 29.32 | 15.96% |
| 2020-07-14 | 7 | 40.0 | 32.0 | 35.00 | 35.31 | -0.88% |
| 2020-07-20 | 7 | 40.5 | 32.0 | 35.93 | 37.14 | -3.26% |
| 2020-07-29 | 7 | 45.0 | 39.0 | 40.93 | 37.53 | 9.06% |
| 2020-08-27 | 8 | 46.0 | 39.0 | 41.56 | 37.72 | 10.18% |
| 2020-09-09 | 9 | 46.0 | 39.0 | 42.06 | 36.94 | 13.86% |
| 2020-10-03 | 9 | 46.0 | 39.0 | 42.06 | 36.08 | 16.57% |
| 2020-10-27 | 9 | 50.0 | 40.5 | 46.28 | 41.25 | 12.19% |
| 2020-11-19 | 9 | 50.0 | 40.5 | 46.61 | 42.73 | 9.08% |
| 2020-12-07 | 9 | 50.0 | 40.5 | 46.61 | 49.21 | -5.28% |
| 2020-12-09 | 9 | 50.0 | 40.5 | 46.61 | 49.52 | -5.88% |
| 2020-12-19 | 10 | 60.0 | 40.5 | 47.95 | 53.62 | -10.57% |
| 2020-12-26 | 10 | 60.0 | 40.5 | 47.95 | 55.40 | -13.45% |
| 2021-01-02 | 10 | 60.0 | 40.5 | 47.95 | 53.84 | -10.94% |
| 2021-01-09 | 10 | 62.0 | 46.0 | 52.50 | 52.44 | 0.11% |
| 2021-01-16 | 10 | 62.0 | 46.0 | 52.50 | 52.78 | -0.53% |
| 2021-01-23 | 10 | 62.0 | 46.0 | 52.50 | 56.03 | -6.3% |
| 2021-01-30 | 11 | 70.0 | 46.0 | 55.82 | 53.02 | 5.28% |
| 2021-02-06 | 11 | 70.0 | 46.0 | 57.27 | 55.00 | 4.13% |
| 2021-02-13 | 11 | 70.0 | 46.0 | 57.27 | 59.88 | -4.36% |
| 2021-02-20 | 11 | 70.0 | 46.0 | 57.27 | 56.56 | 1.26% |
| 2021-02-27 | 10 | 70.0 | 60.0 | 64.60 | 50.97 | 26.74% |
| 2021-03-06 | 10 | 70.0 | 60.0 | 64.60 | 43.25 | 49.36% |
| 2021-03-13 | 10 | 66.0 | 60.0 | 63.60 | 49.23 | 29.19% |
| 2021-03-20 | 10 | 66.0 | 60.0 | 63.60 | 50.18 | 26.74% |
| 2021-04-03 | 10 | 66.0 | 60.0 | 63.20 | 48.53 | 30.23% |
| 2021-04-10 | 10 | 66.0 | 60.0 | 63.20 | 48.17 | 31.2% |
NEO Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.29 | 6 | 5 | 1 | 0 | 0 | 12 |
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- Neogenomics Inc's variance in analysts' estimates is less than 88.06% of stocks in the mid market cap category.
- The number of analysts covering the stock of NEO is greater than 82.59% of Healthcare stocks.
- NEO has a higher upside potential (average analyst target price relative to current price) than 79.41% of stocks in the mid market cap category.
- Neogenomics Inc's average analyst price target is higher than 78.14% of Healthcare stocks.
In the Business Services industry, ACCD, WSC and SPT are the three stocks most similar to Neogenomics Inc regarding the price target and analyst recommendation information presented here.
Is NEO a Buy, Hold or Sell? See the POWR Ratings now!